The issue: Due to a shortage of Canadian-labelled levofloxacin 5 mg/mL X 100 mL ready-to-use IV bags from Pfizer, Health Canada has authorized the importation of a US-labelled product from Hikma Pharmaceuticals.
Newsroom
Issue: betamethasone 0.05 mg/mL X 100 mL rectal enemas have been discontinued from the sole source vendor in Canada. Use of this product in NH is very low across all facilities. Current inventory will expire shortly and will not be replaced once depleted.
Resolution: The shortage of framycetin/gramicidin/ dexamethasone (5 mg-0.05 mg-0.5 mg/mL) eye/ear drops (Sofracort®) has been resolved by the manufacturer.
The issue: lorazepam 4 mg/mL X 1 mL injectable is currently on backorder from the sole source vendor in Canada. NH has approximately four to six weeks of stock in pharmacies and clinical areas.
Estimated availability: November 2022
The issue: hydrOXYzine 10 mg oral capsules are on backorder from the sole vendor in Canada. Based on historical use, NH has approximately two to three months of stock in pharmacies and wardstock locations; however, the ETA for resupply is not until 2023
If you have patients who may be at increased risk for acquiring HIV, correct and consistent use of pre-exposure prophylaxis (PrEP) can help.
The issue: Methotrimeprazine 25 mg/mL x 1 mL injectable is on backorder from the only manufacturer in Canada, Sanofi-Aventis. NH currently has approximately 8 weeks of inventory in pharmacies and wardstock locations and will likely stock out without conservation measures.